undamentalytics Newsletter
Sign in

Healthcare Realty Trust Inc (HR) stock

Add to watchlist

Add holding +

NYSE: HR NYSE Health Care REITs Next results ~February 11, 2027

C Fundamentals grade

Healthcare Realty Trust Inc is a US-listed company in the health care REITs industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$24

Valuation models combined (2)

Base case. Range ~$20–$26. Weighted average of 2 models (funds-from-operations model, dividend discount (growing dividend)), the funds-from-operations model counting double.

Price vs value

No Buy/Hold/Sell rating is issued: only 2 valuation models apply; a rating needs 3.

Healthcare Realty Trust Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders2 buying, 2 selling2 purchases and 2 sales by directors and officers, last 12 monthsInsider trades
  • Funds220 adding, 182 cuttingOf 44 active managers that changed their stake, 22 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Healthcare Realty Trust files

10-Q filed October 29: Healthcare Realty Trust

Model value +14.8%

Revenue for the twelve months to September 2026 came in at $1.13bn, down 5.8% on a year earlier, a pace little changed from the prior quarter. That leaves Healthcare Realty Trust last of the 16 health care REITs we cover on growth. Despite the weak top line, our model value has risen, moving from $20.39 to $23.40 a share. The shares trade at $17.89, a noticeable discount to that model value.

Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where Healthcare Realty Trust stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $1.14bn, down 6.3% on a year earlier, about the same pace as a quarter earlier. That puts it 22 of 22 for growth among the real estate investment trusts companies we cover. Our valuation models combined value is $20.44 a share, against a share price of $17.71.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 11, 2027 (estimated)

Healthcare Realty Trust Inc's trailing-twelve-month revenue fell 5.8% year on year, with a free-cash-flow margin of -5.5%. Where it stands out: change in share count of -1.4% ranks 1 of 17 health care reits companies we cover. Where it lags: revenue growth of -5.8% ranks 17 of 17 health care reits companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 56.8% while net income grew 87.8%: a 31pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 1.4% in a year, so each share owns more of the business.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 100.0% over 90 days.

Things to watch

  • Revenue shrinking. Revenue fell 5.8% over the last 12 months.
  • Burning cash. Free cash flow was -5.5% of revenue over the last 12 months.
  • High debt. Long-term debt exceeds cash by $4.2bn, more than 1.5 times annual revenue.
  • Below peers: net margin. Net margin of -4.0% ranks 15 of 17 health care reits companies we cover (median 7.8%).
  • Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.

Latest results: FY2026 Q3

Filed October 29, 2026
Earnings per share
$0.03 against an average estimate of $0.00: beat by 0.0%
Revenue
$287m, down 3.7% on a year earlier
Share reaction
+5.5% in the first session after the results on October 29, 2026, against -2.1% for the S&P 500
Guidance given
earnings per share $-0.15 to $-0.11 (full year 2026); NAREIT FFO per share $1.48 to $1.52 (full year 2026)
Next report
October 29, 2026; average EPS estimate $0.00

Healthcare Realty Trust's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.4%
  • 1 week+6.3%
  • 1 month+9.4%
  • This year+17.1%
  • 1 year+13.5%
  • 5 years-18.6%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$1.1B
Net margin
-4.0%
EPS (TTM, diluted)
$-0.13

Growth

Revenue growth
−5.8%
Change in growth rate
+0.5 pts
Share count change
−1.4%

Earnings

Last results
October 29, 2026
Next results (est.)
February 11, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Guidance
  3. Announcement
  4. Announcement
  5. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Healthcare Realty Trust Inc valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 2 valuation models apply; a rating needs 3.

Valuation models

We value Healthcare Realty Trust Inc as an equity reit, with every model that fits that kind of business. Cost of equity 7.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.59 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Funds-from-operations model Funds from operations growing 2.5% a year, discounted at 8%. ~$26 ~$22–$31 Primary model, counts double
Price-to-FFO vs peers Funds from operations per share times peers' typical (harmonic-mean) price-to-FFO. ~$0.5 ~$12–$24 Left out: out of range vs price (0.03x)
Dividend discount (growing dividend) Today's dividend growing 2.5% a year, discounted at the cost of equity. ~$20 ~$16–$24 Included
Combined value Weighted average of the models that apply: the primary model (funds-from-operations model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$24 ~$20–$26 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Healthcare Realty Trust Inc with equity REITs in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

37 /100

Weak moat

How hard Healthcare Realty Trust's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median 0.5% of total assets over 10 years.

  • Durability 14 / 20

    Operating margin has been a median 20.7%; its worst year was 10.8%.

  • Cash conversion 6 / 20

    Free cash flow was positive in 5 of 10 years, at a median 1.7% of revenue.

  • Discipline 10 / 20

    The diluted share count rose 63.6% over five years; stock-based pay has been a median 1.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.10 +86% $1.1bn −5%
Next $0.04 — $1.2bn +3%

Next year's EPS estimate has moved +100.0% in 90 days, across 2 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +252.3% on 90 days ago. In the last 30 days, 0 analysts raised Healthcare Realty Trust Inc's forecast and 0 cut it.

Consensus EPS forecast Healthcare Realty Trust Inc, last 90 days
−$0.15 −$0.10 −$0.05 $0.00 $0.05 $0.10 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.03 Current fiscal year, 60 days ago: −$0.10 Current fiscal year, 30 days ago: −$0.10 Current fiscal year, 7 days ago: −$0.10 Current fiscal year, Now: −$0.10 −$0.10 Next fiscal year, 90 days ago: $0.02 Next fiscal year, 60 days ago: $0.02 Next fiscal year, 30 days ago: $0.07 Next fiscal year, 7 days ago: $0.04 Next fiscal year, Now: $0.04 $0.04

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.03$0.02
60 days ago −$0.10$0.02
30 days ago −$0.10$0.07
7 days ago −$0.10$0.04
Now −$0.10$0.04

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $0.00 $0.03 0.0%
Jun 2026 −$0.02 −$0.13 −691.7%
Mar 2026 −$0.03 $0.00 +100.0%
Dec 2025 −$0.03 −$0.03 −10.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 29, 2026
  • Earnings per share full year 2026 $-0.15 to $-0.11 GAAP Maintained
    “Earnings per share $(0.05) $(0.15) $(0.11) $(0.15) $(0.11)” source
  • NAREIT FFO per share full year 2026 $1.48 to $1.52 Non-GAAP Raised
    “NAREIT FFO per share $0.38 $1.45 $1.51 $1.48 $1.52” source
  • Normalized FFO per share full year 2026 $1.65 to $1.67 Non-GAAP Raised
    “Normalized FFO per share $0.42 $1.62 $1.66 $1.65 $1.67” source
  • Same Store Cash NOI growth full year 2026 5% growth to 5.25% growth Non-GAAP Raised
    “Same Store Cash NOI growth 5.1 % 4.25 % 5.00 % 5.00 % 5.25 %” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

13 analysts, Oct 2026
Buy538%
Hold862%
Sell00%

Monthly trend

  1. Oct 202623813
  2. Sep 202622913
  3. Aug 202622913
  4. Jul 202622913

Counts of recommendations published by analysts covering Healthcare Realty Trust Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
9.3%
of tradable shares
Days to cover
3.59
at average volume
Short interest, 1 month
+9%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.6%
of shares
Employees
539
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +13.5%

$16.84 on October 31, 2025 to $19.12

ThenNowEffect
Revenue (last 12 months) $1.2bn $1.1bn −6.3%
P/S multiple 4.9x 5.8x +19.4%
Share count 352m 347m +1.4%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years +57.3%

$12.15 on November 3, 2023 to $19.12

ThenNowEffect
Revenue (last 12 months) $1.3bn $1.1bn −13.0%
P/S multiple 2.9x 5.8x +102.7%
Share count 310m 347m −10.8%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
HR+16%−34%−4%+6%+7%+17%
Industry peers (median)+4%−15%+15%+19%+26%+11%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
HR58%25%58%67%50%64%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
HR−9%−38%−32%−24%−15%−22%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 54% from October 28, 2021 to March 14, 2024. Getting back needed a 116% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$15.74 – $21.60
From 52-week high
−11.5%
vs 50-day average
+5.2%
vs 200-day average
+3.0%
Volatility (1 year)
20%
Beta vs S&P 500
0.07

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±3.0%
After a week
6 up, 5 down
typical move ±3.9%
After a month
9 up, 2 down
typical move ±5.4%
Results releasedNext dayS&P 500 next day5 days21 days
October 29, 2026 +5.5% −2.1% — —
July 30, 2026 −3.7% +2.4% −7.4% −11.9%
April 30, 2026 +4.3% +1.3% +8.3% +6.8%
February 12, 2026 +3.3% −1.5% +4.4% +5.7%
October 30, 2025 −0.2% −0.8% +0.9% +3.5%
July 31, 2025 +6.3% −2.0% +8.4% +13.3%
May 1, 2025 −2.1% +2.2% −1.4% −5.6%
February 19, 2025 −2.4% −0.2% −1.6% +0.3%
October 30, 2024 −5.3% −2.3% −5.7% +2.8%
October 29, 2024 −1.6% −0.1% −2.0% +4.9%
August 2, 2024 −0.3% −4.7% +2.1% +4.3%
July 30, 2024 −1.2% +1.1% +0.9% +0.5%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Healthcare Realty Trust Inc in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Healthcare Realty Trust Inc
$1.1B $1.2B $1.3B $1.4B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $1.3B Revenue (TTM), FY24 Q1: $1.3B Revenue (TTM), FY24 Q2: $1.3B Revenue (TTM), FY24 Q3: $1.3B Revenue (TTM), FY24 Q4: $1.3B Revenue (TTM), FY25 Q1: $1.2B Revenue (TTM), FY25 Q2: $1.2B Revenue (TTM), FY25 Q3: $1.2B Revenue (TTM), FY25 Q4: $1.2B Revenue (TTM), FY26 Q1: $1.2B Revenue (TTM), FY26 Q2: $1.1B Revenue (TTM), FY26 Q3: $1.1B $1.1B

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $1.3B
FY24 Q1 $1.3B
FY24 Q2 $1.3B
FY24 Q3 $1.3B
FY24 Q4 $1.3B
FY25 Q1 $1.2B
FY25 Q2 $1.2B
FY25 Q3 $1.2B
FY25 Q4 $1.2B
FY26 Q1 $1.2B
FY26 Q2 $1.1B
FY26 Q3 $1.1B
Revenue growth, TTM YoY Healthcare Realty Trust Inc
-20% 0% 20% 40% 60% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 44.1% Revenue growth, TTM YoY, FY24 Q1: 19.1% Revenue growth, TTM YoY, FY24 Q2: 0.0% Revenue growth, TTM YoY, FY24 Q3: -4.6% Revenue growth, TTM YoY, FY24 Q4: -5.6% Revenue growth, TTM YoY, FY25 Q1: -7.3% Revenue growth, TTM YoY, FY25 Q2: -7.2% Revenue growth, TTM YoY, FY25 Q3: -6.6% Revenue growth, TTM YoY, FY25 Q4: -6.9% Revenue growth, TTM YoY, FY26 Q1: -6.4% Revenue growth, TTM YoY, FY26 Q2: -6.3% Revenue growth, TTM YoY, FY26 Q3: -5.8% -5.8%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 44.1%
FY24 Q1 19.1%
FY24 Q2 0.0%
FY24 Q3 -4.6%
FY24 Q4 -5.6%
FY25 Q1 -7.3%
FY25 Q2 -7.2%
FY25 Q3 -6.6%
FY25 Q4 -6.9%
FY26 Q1 -6.4%
FY26 Q2 -6.3%
FY26 Q3 -5.8%
Operating margin (TTM) Healthcare Realty Trust Inc
18% 20% 22% 24% FY15 Q4 FY16 Q3 FY17 Q2 FY18 Q3 Operating margin (TTM), FY15 Q4: 23.2% Operating margin (TTM), FY16 Q1: 23.7% Operating margin (TTM), FY16 Q2: 23.3% Operating margin (TTM), FY16 Q3: 23.0% Operating margin (TTM), FY16 Q4: 22.1% Operating margin (TTM), FY17 Q1: 21.7% Operating margin (TTM), FY17 Q2: 20.2% Operating margin (TTM), FY17 Q3: 20.8% Operating margin (TTM), FY17 Q4: 20.1% Operating margin (TTM), FY18 Q1: 19.5% Operating margin (TTM), FY18 Q2: 21.3% Operating margin (TTM), FY18 Q3: 20.6% 20.6%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Operating margin (TTM)
FY15 Q4 23.2%
FY16 Q1 23.7%
FY16 Q2 23.3%
FY16 Q3 23.0%
FY16 Q4 22.1%
FY17 Q1 21.7%
FY17 Q2 20.2%
FY17 Q3 20.8%
FY17 Q4 20.1%
FY18 Q1 19.5%
FY18 Q2 21.3%
FY18 Q3 20.6%
FCF margin (TTM) Healthcare Realty Trust Inc
-20% -15% -10% -5% 0% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: -17.2% FCF margin (TTM), FY24 Q1: -16.3% FCF margin (TTM), FY24 Q2: -17.1% FCF margin (TTM), FY24 Q3: -15.8% FCF margin (TTM), FY24 Q4: -13.7% FCF margin (TTM), FY25 Q1: -14.1% FCF margin (TTM), FY25 Q2: -13.1% FCF margin (TTM), FY25 Q3: -12.1% FCF margin (TTM), FY25 Q4: -10.0% FCF margin (TTM), FY26 Q1: -7.9% FCF margin (TTM), FY26 Q2: -7.6% FCF margin (TTM), FY26 Q3: -5.5% -5.5%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 -17.2%
FY24 Q1 -16.3%
FY24 Q2 -17.1%
FY24 Q3 -15.8%
FY24 Q4 -13.7%
FY25 Q1 -14.1%
FY25 Q2 -13.1%
FY25 Q3 -12.1%
FY25 Q4 -10.0%
FY26 Q1 -7.9%
FY26 Q2 -7.6%
FY26 Q3 -5.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 129 203 272 300 322 372 404 461 614 696 692 500 535 933 1,344 1,268 1,181 1,134
EBITDA 52 100 153 147 188 224 248 279 369 — — — — — — — — —
Operating income −1 22 46 30 66 83 94 102 124 — — — — — — — — —
Net income −25 −8 6 −24 24 45 33 46 64 213 30 72 67 41 −278 −654 −246 −45
Diluted EPS −$0.44 −$0.10 $0.04 −$0.22 $0.21 $0.37 $0.26 $0.33 $0.34 $1.02 $0.14 $0.52 $0.45 $0.15 −$0.74 −$1.81 −$0.71 −$0.13
Growth (year on year)
Revenue — +56.8% +34.0% +10.1% +7.3% +15.5% +8.7% +14.1% +33.2% +13.4% −0.6% −27.8% +7.0% +74.4% +44.1% −5.6% −6.9% −5.8%
EBITDA — +91.0% +52.8% −3.9% +28.0% +18.9% +10.8% +12.5% +32.2% — — — — — — — — —
Operating income — — +115.4% −34.3% +117.8% +25.4% +12.7% +8.9% +21.3% — — — — — — — — —
Net income — — — −540.8% — +87.0% −27.4% +39.4% +39.2% +234.0% −85.9% +139.4% −7.7% −38.6% −780.4% — — —
Diluted EPS — — — −650.0% — +76.2% −29.7% +26.9% +3.0% +200.0% −86.3% +271.4% −13.5% −66.7% −593.3% — — —
Margins
EBITDA margin 40.5% 49.3% 56.2% 49.0% 58.4% 60.2% 61.3% 60.5% 60.0% — — — — — — — — —
Operating margin −0.9% 10.6% 17.0% 10.2% 20.6% 22.4% 23.2% 22.1% 20.1% — — — — — — — — —
Net margin −19.4% −3.9% 2.0% −8.2% 7.5% 12.2% 8.2% 10.0% 10.4% 30.7% 4.4% 14.4% 12.5% 4.4% −20.7% −51.6% −20.8% −4.0%
Free-cash-flow margin 9.7% 21.5% 35.2% 31.3% 38.1% 37.5% 40.1% 34.9% 39.5% 37.3% 36.0% 79.1% 25.3% 29.2% 37.2% 39.5% 38.7% 39.7%
Cash flow
Cash from operations 22 59 112 117 148 168 191 204 308 337 340 470 233 273 500 502 457 450
Capital spending 9 15 16 23 25 29 29 43 65 78 92 75 97 0 0 0 0 0
Free cash flow 13 44 96 94 122 139 162 161 243 260 249 395 135 273 500 502 457 450
Stock-based pay 1 1 3 17 6 4 6 7 7 10 10 10 11 20 14 32 22 18
Free cash flow after stock pay 12 42 93 76 117 135 156 154 236 250 239 385 125 252 486 470 435 432
Balance sheet
Cash 219 29 69 16 18 10 13 11 100 126 33 115 13 61 26 69 26 17
Total debt 0 0 639 1,037 1,214 1,413 1,600 1,781 2,802 2,561 2,764 3,050 1,801 5,352 4,995 4,663 3,911 4,249
Net debt (negative = net cash) −219 −29 570 1,021 1,196 1,402 1,587 1,770 2,702 2,435 2,731 2,935 1,788 5,291 4,969 4,594 3,885 4,232
Diluted shares 56m 83m 112m 111m 115m 121m 128m 140m 185m 210m 210m 134m 143m 254m 379m 366m 350m 345m
Returned to shareholders
Dividends 40 60 85 93 129 137 146 159 207 253 256 163 175 284 472 458 387 333
Buybacks 16 52 38 183 1 1 2 3 3 70 12 1 4 3 2 9 4 3
Total returned 56 112 122 276 130 138 148 162 211 323 268 164 179 287 475 467 391 336

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$3.2M
Dividends (TTM)
$333M
Returned to shareholders
-534%
of free cash flow
Buybacks, last 3 fiscal years
$15.2M
Diluted share count
−1.4%
year over year
Total shareholder yield
5.2%
dividends 5.1% + buybacks 0.1% of market value

Competitors: side by side with peers

Closest by revenue in health care reits
Last 12 months unless stated HR MPT OHI SBRA DHC CTRE Median
Revenue, last 12 months $1.1bn $1.0bn $1.3bn $919m $1.5bn $571m $919m
Revenue growth, last 12 months −5.8% 10.6% 15.0% 23.4% −3.8% 53.0% 15.0%
Revenue growth, 3-year average −5.7% −10.5% 14.6% 12.3% 2.2% 40.9% 12.0%
Revenue growth, latest quarter −3.7% 7.9% 16.2% 31.3% −5.4% 43.5% 11.1%
Gross margin — 90.3% — — — 100.0% 60.1%
Operating margin 20.6% 68.9% 43.5% — 24.9% — 35.3%
Operating margin, 3-year average 21.5% 63.9% 53.9% — 27.4% — 35.7%
Net margin −4.0% −3.0% 67.0% 7.8% −10.3% 62.2% 7.8%
Cash from operations / revenue 39.7% 22.3% 69.5% 43.6% 3.7% 78.2% 41.7%
Free-cash-flow margin −5.5% −5.2% 63.6% 19.0% −4.4% 58.3% 15.1%
Free-cash-flow margin, 3-year average −11.2% −6.5% 66.1% 20.4% −7.6% 59.7% 19.1%
Stock pay / revenue 1.6% 1.2% 4.1% 1.8% 0.1% 2.0% 1.6%
Change in share count −1.4% −0.2% 7.9% 5.9% 0.3% 23.8% 6.1%

Median of all 17 companies we cover in health care reits. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

17 health care reits companies
Measure Company Peer median Rank
Revenue growth Growth -5.8% 15.0% 17 of 17
Change in growth rate Growth +0.5pp +1.1pp 11 of 17
Net margin Profitability -4.0% 7.8% 15 of 17
Stock pay as % of revenue Cash generation 1.6% 1.8% 7 of 16
Long-term debt as % of assets Balance sheet 47.4% 47.4% 8 of 14
Change in share count Balance sheet -1.4% 6.1% 1 of 17

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Management Fee Income $19.6M ▲ 99.5%
Parking Income $8.6M ▼ 7.8%

These categories overlap or exclude eliminations, so shares aren't shown.

From Healthcare Realty Trust Inc's 10-K filed February 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$7.6B
Institutions reporting
457
Shares held vs prior quarter
▲ 0.8%
Positions opened / closed
53 / 38

Top buyers and sellers, Q2 2026: 220 institutions bought and 182 sold ; the biggest buyer was Deutsche Bank Ag\ (+4.4M shares) and the biggest seller Centersquare Investment Management LLC (−6.4M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.2B 57.0M 15.1% ▲ 4.0%
Cohen & Steers, Inc. $1.1B 53.3M 14.1% ▲ 1.6%
Vanguard Portfolio Management LLC $586M 29.0M 7.7% ▲ 1.5%
State Street Corp $338M 16.7M 4.4% ▼ 1.9%
Price T Rowe Associates Inc $324M 16.1M 4.3% ▲ 0.5%
Vanguard Capital Management LLC $314M 15.6M 4.1% 0.0%
Resolution Capital Ltd $245M 12.1M 3.2% ▼ 13.5%
APG Asset Management Us Inc. $207M 10.2M 2.7% 0.0%
Daiwa Securities Group Inc. $163M 8.1M 2.1% ▼ 3.8%
Charles Schwab Investment Management Inc $150M 7.4M 2.0% ▲ 1.5%
Geode Capital Management, LLC $147M 7.3M 1.9% ▲ 0.6%
Rush Island Management, LP $105M 5.2M 1.4% ▼ 27.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Healthcare Realty Trust Inc's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $181,087 2 trades by 2 insiders, last 12 months Insider sales History → $926,184 2 trades by 2 insiders · 0% under pre-set plans
Net ▼ $745,097 net selling
Insider Date Trade Shares Price Value
Hull Robert E EVP and COO September 8, 2026 Sell 21,000 $19.11 $401,310
Callaway Amanda L SVP & Chief Accounting Officer June 23, 2026 Sell 25,767 $20.37 $524,874
Bohjalian Thomas N Director March 6, 2026 Buy 10,000 $18.09 $180,900
Gabbay Daniel EVP, Chief Financial Officer March 4, 2026 Buy 10 $18.74 $187

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 3 trades and filings

No trades in Healthcare Realty Trust Inc disclosed in the last 12 months; 3 earlier trades on record.

  • Donna Shalala(FL):Sale (full), $1,001 - $15,000, traded February 20, 2019, filed April 27, 2020
  • David B. McKinley(R-WV 1):Sale (full), $15,001 - $50,000, traded December 17, 2018, filed January 9, 2019
  • Raúl M. Grijalva(D-AZ 3):Sale (full), $1,001 - $15,000, traded May 11, 2015, filed June 10, 2015

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 11, 2027 estimated from the company's past filing pattern, not announced

  • October 29, 2026
  • July 30, 2026
  • April 30, 2026
  • February 12, 2026
  • October 30, 2025
  • July 31, 2025

Recent SEC filings

Data status

When each part of this page on Healthcare Realty Trust Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Healthcare Realty Trust Inc in brief

What does Healthcare Realty Trust Inc do?
Healthcare Realty Trust Inc is a US-listed company in the health care REITs industry. Its financial year ends in December.
What is Healthcare Realty Trust Inc's stock ticker?
Healthcare Realty Trust Inc trades under the ticker HR on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Healthcare Realty Trust Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Healthcare Realty Trust Inc reported revenue of $1.1B, 5.8% lower than a year earlier, according to its SEC filings.
What is Healthcare Realty Trust Inc's free cash flow?
Healthcare Realty Trust Inc's free-cash-flow margin is -5.5% of revenue over the trailing twelve months.
Who are Healthcare Realty Trust Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Cohen & Steers, Inc. and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Healthcare Realty Trust Inc buying back stock, and does it pay a dividend?
Healthcare Realty Trust Inc spent $3.2M on share repurchases over the trailing twelve months, and its diluted share count fell 1.4% over the year.
What is Healthcare Realty Trust Inc's market cap?
On November 2, 2026, Healthcare Realty Trust Inc's market capitalisation was about $6.6B and net debt of $4.2B. Market figures come from third-party market data and may be delayed.
Does Healthcare Realty Trust Inc pay a dividend?
Yes: Healthcare Realty Trust Inc paid $333M in dividends over the trailing twelve months, a dividend yield of 5.12%.
Who are Healthcare Realty Trust Inc's competitors?
In our Health Care REITs peer group, the companies closest to Healthcare Realty Trust Inc are Medical Properties Trust Inc, Omega Healthcare Investors Inc, Sabra Health Care Reit, Inc., Diversified Healthcare Trust and Caretrust Reit, Inc. The side-by-side comparison below sets their revenue, margins and growth against Healthcare Realty Trust Inc's.
Are insiders buying or selling Healthcare Realty Trust Inc stock?
Over the last 12 months, Healthcare Realty Trust Inc's directors and officers reported 2 open-market purchases and 2 sales on Form 4. The insider trading page charts every trade.
When is Healthcare Realty Trust Inc's next earnings date?
Around February 11, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Healthcare Realty Trust Inc announces its own schedule.